Amgen Inc. Stock News

The U.S. health regulator said on Friday it has revised the prescribing information on Amgen's drug to treat bone loss to include a boxed warning related to risk of severely low calcium level in certa

Amgen (AMGN) closed the most recent trading day at $304.08, moving +0.2% from the previous trading session.

Two sets of reliable stock market cycles have topped. Technically, the market does not appear as weak as expected.

Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

The final trades of the day with the Fast Money traders.

The GLP-1 segment is an important class of drugs for multiple cardiometabolic diseases and is gaining significant popularity.

Amgen (AMGN) reachead $303.10 at the closing of the latest trading day, reflecting a -0.48% change compared to its last close.

Here are three stocks in the health care sector that could provide further upside potential based on their improving technical characteristics.

“The Dogs of the Dow” system involves purchasing the index's 10 stocks with the highest dividend yields at the end of each year. Using the technique has a few major advantages.

Xeris Biopharma Holdings (NASDAQ:XERS) announced an exclusive worldwide license agreement with Amgen for the development, manufacturing, and commercialization of a subcutaneous formulation of teprotum

Up 2% five trading days into the new year, global health care stocks have already matched their return for all of 2023. It's very early, but the sector has outpaced all other 10 economic groups since

How To Build A Dividend Growth Portfolio As A 'Young Investor' With $100,000

Amgen Inc. (AMGN) Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024 (Transcript)

Nvidia Corp. NVDA, +4.72% is doubling down on artificial-intelligence-powered drug discovery and development, announcing expanded partnerships Monday with Amgen Inc. AMGN, +1.26% and Recursion Pharmac

The Pharmaceutical segment offers human health pharmaceutical products in: Oncology, Hospital acute care Immunology Neuroscience Virology Cardiovascular and diabetes Vaccine products, such as preventi